Theophylline pharmacokinetics in pregnancy

Publisher Website
Google Scholar
Abstract
Theophylline pharmacokinetics were studied serially in five women during and after pregnancy. Theophylline protein binding was reduced to 11.1% ± 4.7% (P < 0.01) and 13.0% ± 5.9% (P < 0.01) during the second and third trimesters of pregnancy, respectively, compared with 28.1% ± 2.8% when the patients were more than 6 months postpartum. Similar comparisons indicate that theophylline distribution volume and elimination t1/2 were increased from 30.7 ± 4.4 L and 262 ±57 minutes to 36.8 ± 4.2 L (P < 0.05) and 389 ± 73 minutes (P < 0.01) in the third trimester of pregnancy. In the second and third trimesters, intrinsic nonrenal clearance was reduced to 0.82 ± 0.25 ml/min · kg (P < 0.05) and 0.67 ± 0.18 ml/min • kg (P < 0.01) compared with a remote postpartum value of 1.25 ± 0.37 ml/min · kg. However, these reductions were offset by increases in theophylline intrinsic renal clearance so that apparent reductions in the overall unbound clearance of this drug did not reach statistical significance either during pregnancy or in the early postpartum period. Clinical Pharmacology and Therapeutics (1986) 40, 321–328; doi:10.1038/clpt.1986.183